These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19369534)
1. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. Tapsall J; Read P; Carmody C; Bourne C; Ray S; Limnios A; Sloots T; Whiley D J Med Microbiol; 2009 May; 58(Pt 5):683-687. PubMed ID: 19369534 [TBL] [Abstract][Full Text] [Related]
2. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533 [TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Unemo M; Golparian D; Hestner A Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645 [TBL] [Abstract][Full Text] [Related]
4. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Unemo M; Golparian D; Potočnik M; Jeverica S Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003 [TBL] [Abstract][Full Text] [Related]
5. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection. Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490 [TBL] [Abstract][Full Text] [Related]
6. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207 [No Abstract] [Full Text] [Related]
7. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study. Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630 [TBL] [Abstract][Full Text] [Related]
8. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia. Hustig A; Bell C; Waddell R Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709 [TBL] [Abstract][Full Text] [Related]
9. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis? Hamasuna R; Takahashi S; Uehara S; Matsumoto T J Infect Chemother; 2012 Jun; 18(3):410-3. PubMed ID: 22302695 [TBL] [Abstract][Full Text] [Related]
10. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study. Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976 [TBL] [Abstract][Full Text] [Related]
11. Isolated pharyngeal Neisseria gonorrhoeae in heterosexual male contacts. Thomson-Glover R; Brown R; Edirisinghe DN Int J STD AIDS; 2013 Dec; 24(12):983-5. PubMed ID: 23970625 [TBL] [Abstract][Full Text] [Related]
12. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Muratani T; Inatomi H; Ando Y; Kawai S; Akasaka S; Matsumoto T Int J Urol; 2008 Sep; 15(9):837-42. PubMed ID: 18665871 [TBL] [Abstract][Full Text] [Related]
13. One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia. Read PJ; Limnios EA; McNulty A; Whiley D; Lahra MM Sex Health; 2013 Nov; 10(5):460-2. PubMed ID: 24028864 [TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae among heterosexual men in Japan. Wada K; Uehara S; Mitsuhata R; Kariyama R; Nose H; Sako S; Ishii A; Watanabe T; Matsumoto A; Monden K; Uno S; Araki T; Kumon H J Infect Chemother; 2012 Oct; 18(5):729-33. PubMed ID: 22491994 [TBL] [Abstract][Full Text] [Related]
18. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L; Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291 [TBL] [Abstract][Full Text] [Related]
19. Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea. Pabst KM; Siegel NA; Smith S; Black JR; Handsfield HH; Hook EW Sex Transm Dis; 1989; 16(3):148-51. PubMed ID: 2510329 [TBL] [Abstract][Full Text] [Related]
20. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection. Matsumoto T; Muratani T; Takahashi K; Ikuyama T; Yokoo D; Ando Y; Sato Y; Kurashima M; Shimokawa H; Yanai S J Infect Chemother; 2006 Jun; 12(3):145-7. PubMed ID: 16826347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]